Loading data
CRTONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.94 bn USD | 1.93 bn USD | 1.95 bn USD | 2.02 bn USD | 2.25 bn USD |
| Cost of revenue | 770.28 m USD | 811.81 m USD | 926.84 m USD | 1.09 bn USD | 1.33 bn USD |
| Gross profit | 1.05 bn USD | 982.97 m USD | 863.04 m USD | 795.2 m USD | 781.94 m USD |
| Research and development expense | 283.3 m USD | 279.34 m USD | 242.29 m USD | 187.6 m USD | 151.82 m USD |
| Operating profit | 202.77 m USD | 151.4 m USD | 77.22 m USD | 24.28 m USD | 151.88 m USD |
| Interest expense | — | — | 2.24 m USD | 2.03 m USD | 2.27 m USD |
| Profit before tax | 203.57 m USD | 154.5 m USD | 74.73 m USD | 42.06 m USD | 153.82 m USD |
| Income tax expense | 54.2 m USD | 39.78 m USD | 20.08 m USD | 31.19 m USD | 16.17 m USD |
| Net income (reported basis) | 149 m USD | 115 m USD | 55 m USD | 11 m USD | 138 m USD |
| Basic earnings per share | 2.73 USD/share | 2.04 USD/share | 0.95 USD/share | 0.15 USD/share | 2.21 USD/share |
| Diluted earnings per share | 2.64 USD/share | 1.9 USD/share | 0.88 USD/share | 0.14 USD/share | 2.09 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.